75 related articles for article (PubMed ID: 23242609)
1. High level of FOXC1 expression is associated with poor prognosis in pancreatic ductal adenocarcinoma.
Wang L; Gu F; Liu CY; Wang RJ; Li J; Xu JY
Tumour Biol; 2013 Apr; 34(2):853-8. PubMed ID: 23242609
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1.
Yu C; Wang M; Li Z; Xiao J; Peng F; Guo X; Deng Y; Jiang J; Sun C
Cell Oncol (Dordr); 2015 Jun; 38(3):173-81. PubMed ID: 25875420
[TBL] [Abstract][Full Text] [Related]
3. SKA3 Expression as a Prognostic Factor for Patients with Pancreatic Adenocarcinoma.
Buchholz K; Durślewicz J; Klimaszewska-Wiśniewska A; Wiśniewska M; Słupski M; Grzanka D
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791174
[TBL] [Abstract][Full Text] [Related]
4. Expression landscape of cancer-FOXP3 and its prognostic value in pancreatic adenocarcinoma.
Gong R; Wang J; Xing Y; Wang J; Chen X; Lei K; Yu Q; Zhao C; Li S; Zhang Y; Wang H; Ren H
Cancer Lett; 2024 May; 590():216838. PubMed ID: 38561039
[TBL] [Abstract][Full Text] [Related]
5. Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance?
Gebauer F; Kemper M; Sauter G; Prehm P; Schumacher U
PLoS One; 2017; 12(6):e0178703. PubMed ID: 28582436
[TBL] [Abstract][Full Text] [Related]
6. PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic marker.
Nigri J; Gironella M; Bressy C; Vila-Navarro E; Roques J; Lac S; Bontemps C; Kozaczyk C; Cros J; Pietrasz D; Maréchal R; Van Laethem JL; Iovanna J; Bachet JB; Folch-Puy E; Tomasini R
Cell Mol Life Sci; 2017 Nov; 74(22):4231-4243. PubMed ID: 28656348
[TBL] [Abstract][Full Text] [Related]
7. Induction of osteopontin expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cells.
Chipitsyna G; Gong Q; Anandanadesan R; Alnajar A; Batra SK; Wittel UA; Cullen DM; Akhter MP; Denhardt DT; Yeo CJ; Arafat HA
Int J Cancer; 2009 Jul; 125(2):276-85. PubMed ID: 19358273
[TBL] [Abstract][Full Text] [Related]
8. Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival.
Bellone G; Smirne C; Mauri FA; Tonel E; Carbone A; Buffolino A; Dughera L; Robecchi A; Pirisi M; Emanuelli G
Cancer Immunol Immunother; 2006 Jun; 55(6):684-98. PubMed ID: 16094523
[TBL] [Abstract][Full Text] [Related]
9. Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival.
Curcio C; Rosso T; Brugiapaglia S; Guadagnin G; Giordano D; Castellino B; Satolli MA; Spadi R; Campra D; Moro F; Papotti MG; Bertero L; Cassoni P; De Angelis C; Langella S; Ferrero A; Armentano S; Bellotti G; Fenocchio E; Nuzzo A; Ciccone G; Novelli F
Clin Exp Med; 2023 Dec; 23(8):5089-5100. PubMed ID: 37910256
[TBL] [Abstract][Full Text] [Related]
10. Systematic analysis of proteome turnover in an organoid model of pancreatic cancer by dSILO.
Ross AB; Gorhe D; Kim JK; Hodapp S; DeVine L; Chan KM; Chio IIC; Jovanovic M; Ayres Pereira M
Cell Rep Methods; 2024 May; 4(5):100760. PubMed ID: 38677284
[TBL] [Abstract][Full Text] [Related]
11. FOXC1: an emerging marker and therapeutic target for cancer.
Han B; Bhowmick N; Qu Y; Chung S; Giuliano AE; Cui X
Oncogene; 2017 Jul; 36(28):3957-3963. PubMed ID: 28288141
[TBL] [Abstract][Full Text] [Related]
12. The Diverse Consequences of
Gilding LN; Somervaille TCP
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30764547
[TBL] [Abstract][Full Text] [Related]
13. FOXC1 plays a crucial role in the growth of pancreatic cancer.
Subramani R; Camacho FA; Levin CI; Flores K; Clift A; Galvez A; Terres M; Rivera S; Kolli SN; Dodderer J; Miranda M; Rodriguez A; Pedroza DA; Chatterjee A; Lakshmanaswamy R
Oncogenesis; 2018 Jul; 7(7):52. PubMed ID: 29976975
[TBL] [Abstract][Full Text] [Related]
14. FoxC1 promotes epithelial-mesenchymal transition through PBX1 dependent transactivation of ZEB2 in esophageal cancer.
Zhu X; Wei L; Bai Y; Wu S; Han S
Am J Cancer Res; 2017; 7(8):1642-1653. PubMed ID: 28861321
[TBL] [Abstract][Full Text] [Related]
15. Exosome-Mediated miR-4792 Transfer Promotes Bladder Cancer Cell Proliferation via Enhanced FOXC1/c-Myc Signaling and Warburg Effect.
Wu JH; Sun KN; Chen ZH; He YJ; Sheng L
J Oncol; 2022; 2022():5680353. PubMed ID: 35096062
[TBL] [Abstract][Full Text] [Related]
16. Therapeutically Targeting Cancers That Overexpress FOXC1: A Transcriptional Driver of Cell Plasticity, Partial EMT, and Cancer Metastasis.
Ray T; Ryusaki T; Ray PS
Front Oncol; 2021; 11():721959. PubMed ID: 34540690
[TBL] [Abstract][Full Text] [Related]
17. The Synergistic Effects of Pyrotinib Combined With Adriamycin on HER2-Positive Breast Cancer.
Wang C; Deng S; Chen J; Xu X; Hu X; Kong D; Liang G; Yuan X; Li Y; Wang X
Front Oncol; 2021; 11():616443. PubMed ID: 34094901
[TBL] [Abstract][Full Text] [Related]
18. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
[TBL] [Abstract][Full Text] [Related]
19. FOXCUT Promotes the Proliferation and Invasion by Activating FOXC1/PI3K/AKT Pathway in Colorectal Cancer.
Zhang X; Yi S; Xing G; Wu H; Zhu Y; Guo X; Zhang L
Cancer Manag Res; 2020; 12():6269-6278. PubMed ID: 32801872
[TBL] [Abstract][Full Text] [Related]
20. FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer.
Hsu HH; Kuo WW; Shih HN; Cheng SF; Yang CK; Chen MC; Tu CC; Viswanadha VP; Liao PH; Huang CY
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31623173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
